Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Prophylactic Tranexamic Acid in Reducing Postpartum Hemorrhage After Cesarean Delivery in Women with Systemic Autoimmune Disease：A Randomized Controlled Trial

NCT06754371 is registered in ClinicalTrials.gov with RenJi Hospital as lead sponsor.

NCT NCT06754371
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06754371 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Prophylactic Tranexamic Acid in Reducing Postpartum Hemorrhage After Cesarean Delivery in Women with Systemic Autoimmune Disease：A Randomized Controlled Trial
Lead sponsor
RenJi Hospital
Phase
Phase 4
Overall status
Recruiting
Start date
January 6, 2025
Completion date
June 30, 2027
Enrollment
276 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

postpartum hemorrhage, systemic autoimmune diseases